NO20081488L - Fotostabil farmasoytisk sammensetning inneholdende brivudine til behandling av herpetisk keratitt - Google Patents
Fotostabil farmasoytisk sammensetning inneholdende brivudine til behandling av herpetisk keratittInfo
- Publication number
- NO20081488L NO20081488L NO20081488A NO20081488A NO20081488L NO 20081488 L NO20081488 L NO 20081488L NO 20081488 A NO20081488 A NO 20081488A NO 20081488 A NO20081488 A NO 20081488A NO 20081488 L NO20081488 L NO 20081488L
- Authority
- NO
- Norway
- Prior art keywords
- composition containing
- photo
- treatment
- pharmaceutical composition
- stable pharmaceutical
- Prior art date
Links
- 229960001169 brivudine Drugs 0.000 title abstract 2
- ODZBBRURCPAEIQ-PIXDULNESA-N helpin Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(\C=C\Br)=C1 ODZBBRURCPAEIQ-PIXDULNESA-N 0.000 title abstract 2
- 208000005100 Herpetic Keratitis Diseases 0.000 title 1
- 206010073938 Ophthalmic herpes simplex Diseases 0.000 title 1
- 201000010884 herpes simplex virus keratitis Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000004372 Polyvinyl alcohol Substances 0.000 abstract 2
- 229920000058 polyacrylate Polymers 0.000 abstract 2
- 229920002451 polyvinyl alcohol Polymers 0.000 abstract 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Inorganic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005046769A DE102005046769A1 (de) | 2005-09-29 | 2005-09-29 | Lichtstabile, brivudinhaltige pharmazeutische Formulierung zur Behandlung von Augenherpes (Herpes Ophthalmicus) |
| PCT/EP2006/009383 WO2007039201A2 (fr) | 2005-09-29 | 2006-09-27 | Composition pharmaceutique photostable contenant de la brivudine pour le traitement de la keratite herpetique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20081488L true NO20081488L (no) | 2008-03-26 |
Family
ID=37561306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20081488A NO20081488L (no) | 2005-09-29 | 2008-03-26 | Fotostabil farmasoytisk sammensetning inneholdende brivudine til behandling av herpetisk keratitt |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US20080249061A1 (fr) |
| EP (1) | EP1940353B1 (fr) |
| JP (1) | JP2009509993A (fr) |
| KR (1) | KR20080053319A (fr) |
| CN (1) | CN101272765A (fr) |
| AP (1) | AP2008004394A0 (fr) |
| AR (1) | AR056551A1 (fr) |
| AT (1) | ATE489076T1 (fr) |
| AU (1) | AU2006299115A1 (fr) |
| BR (1) | BRPI0616449A2 (fr) |
| CA (1) | CA2624111A1 (fr) |
| CR (1) | CR9839A (fr) |
| CY (1) | CY1111059T1 (fr) |
| DE (2) | DE102005046769A1 (fr) |
| DK (1) | DK1940353T3 (fr) |
| EA (1) | EA012975B1 (fr) |
| EC (1) | ECSP088310A (fr) |
| ES (1) | ES2356774T3 (fr) |
| HN (1) | HN2008000497A (fr) |
| HR (1) | HRP20110085T1 (fr) |
| IL (1) | IL190466A0 (fr) |
| MA (1) | MA29887B1 (fr) |
| NO (1) | NO20081488L (fr) |
| PE (1) | PE20070767A1 (fr) |
| PL (1) | PL1940353T3 (fr) |
| PT (1) | PT1940353E (fr) |
| RS (1) | RS51615B (fr) |
| SI (1) | SI1940353T1 (fr) |
| TN (1) | TNSN08094A1 (fr) |
| TW (1) | TW200744664A (fr) |
| UA (1) | UA90911C2 (fr) |
| WO (1) | WO2007039201A2 (fr) |
| ZA (1) | ZA200802729B (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009006130A2 (fr) * | 2007-06-28 | 2009-01-08 | Bausch & Lomb Incorporated | Solution ophtalmique à base d'hyaluronate exempte de sel |
| WO2009100367A2 (fr) * | 2008-02-06 | 2009-08-13 | Adherex Technologies Inc. | Compositions comprenant des inhibiteurs de dpd topiques et procédés d'utilisation correspondants pour le traitement de l'érythrodysesthésie palmo-plantaire |
| DE102009003942A1 (de) * | 2009-01-07 | 2010-07-08 | D2O Biosience Group Ltd., Hamilton | Verwendung von Deuteriumoxid zur Behandlung Virus-basierter Erkrankungen des Auges |
| ES2734269T3 (es) | 2014-01-22 | 2019-12-05 | Visufarma B V | Composición que comprende carragenina tipo iota contra conjuntivitis viral |
| US10610499B2 (en) * | 2016-05-06 | 2020-04-07 | SaCSh Corp. | Ophthalmic compositions |
| CN113712928A (zh) * | 2021-09-29 | 2021-11-30 | 重庆市力扬医药开发有限公司 | 经口腔粘膜吸收的溴夫定药物 |
| EP4623919A1 (fr) | 2024-03-28 | 2025-10-01 | Marinomed Biotech AG | Composition comprenant de l'iota-carraghenane pour le traitement des yeux secs, de la conjonctivite non virale et des pathologies oculaires allergiques |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY136633A (en) * | 2001-01-17 | 2008-11-28 | Berlin Chemie Ag | Stabilized brivudine topical formulations |
| DE10162593A1 (de) * | 2001-12-19 | 2003-07-03 | Menarini Ricerche Spa | Stabilisierte topische Brivudin-Formulierungen |
-
2005
- 2005-09-29 DE DE102005046769A patent/DE102005046769A1/de not_active Withdrawn
-
2006
- 2006-09-27 AT AT06805904T patent/ATE489076T1/de active
- 2006-09-27 SI SI200630913T patent/SI1940353T1/sl unknown
- 2006-09-27 AP AP2008004394A patent/AP2008004394A0/xx unknown
- 2006-09-27 UA UAA200802782A patent/UA90911C2/ru unknown
- 2006-09-27 BR BRPI0616449-8A patent/BRPI0616449A2/pt not_active IP Right Cessation
- 2006-09-27 AU AU2006299115A patent/AU2006299115A1/en not_active Abandoned
- 2006-09-27 CN CNA2006800356965A patent/CN101272765A/zh active Pending
- 2006-09-27 US US12/088,397 patent/US20080249061A1/en not_active Abandoned
- 2006-09-27 WO PCT/EP2006/009383 patent/WO2007039201A2/fr not_active Ceased
- 2006-09-27 ES ES06805904T patent/ES2356774T3/es active Active
- 2006-09-27 DE DE602006018505T patent/DE602006018505D1/de active Active
- 2006-09-27 EA EA200800646A patent/EA012975B1/ru not_active IP Right Cessation
- 2006-09-27 RS RS20110016A patent/RS51615B/sr unknown
- 2006-09-27 CA CA002624111A patent/CA2624111A1/fr not_active Abandoned
- 2006-09-27 JP JP2008532659A patent/JP2009509993A/ja not_active Withdrawn
- 2006-09-27 KR KR1020087007483A patent/KR20080053319A/ko not_active Withdrawn
- 2006-09-27 DK DK06805904.7T patent/DK1940353T3/da active
- 2006-09-27 TW TW095135667A patent/TW200744664A/zh unknown
- 2006-09-27 EP EP06805904A patent/EP1940353B1/fr active Active
- 2006-09-27 PL PL06805904T patent/PL1940353T3/pl unknown
- 2006-09-27 HR HR20110085T patent/HRP20110085T1/hr unknown
- 2006-09-27 PT PT06805904T patent/PT1940353E/pt unknown
- 2006-09-27 ZA ZA200802729A patent/ZA200802729B/xx unknown
- 2006-09-28 PE PE2006001181A patent/PE20070767A1/es not_active Application Discontinuation
- 2006-09-28 AR ARP060104294A patent/AR056551A1/es unknown
-
2008
- 2008-02-28 TN TNP2008000094A patent/TNSN08094A1/en unknown
- 2008-03-25 EC EC2008008310A patent/ECSP088310A/es unknown
- 2008-03-26 NO NO20081488A patent/NO20081488L/no not_active Application Discontinuation
- 2008-03-27 CR CR9839A patent/CR9839A/es not_active Application Discontinuation
- 2008-03-27 HN HN2008000497A patent/HN2008000497A/es unknown
- 2008-03-27 IL IL190466A patent/IL190466A0/en unknown
- 2008-04-24 MA MA30877A patent/MA29887B1/fr unknown
-
2010
- 2010-12-23 CY CY20101101189T patent/CY1111059T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20081488L (no) | Fotostabil farmasoytisk sammensetning inneholdende brivudine til behandling av herpetisk keratitt | |
| NO20081479L (no) | 7-(2-Amino-1-hydroksyetyl)-4-hydroksybenzotiazol-2(3H)-ondenvater som beta2-adrenoceptoragonister | |
| NO20075297L (no) | Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists | |
| NO20074703L (no) | Antibakterielle piperidinderivater | |
| NO20081729L (no) | Nye diazaspiroalkaner og deres anvendelse for behandling av CCR8-medierte sykdommer | |
| WO2006015943A3 (fr) | Préparation d’une pastille à autorisation de sortie élargie, contenant du pramipexole ou un sel de pramipexole pharmaceutiquement acceptable, procédé de fabrication et d’utilisation de cette pastille | |
| WO2007087548A3 (fr) | Composés chimiques | |
| NO20090295L (no) | Substituerte heteroarylderivater | |
| DK1863812T3 (da) | Dipeptidylpeptidase-IV-inhiberende forbindelser, fremgangsmåder til fremstilling af de samme og farmaceutiske sammensætninger indeholdende de samme som aktive midler | |
| EP2308867A3 (fr) | Dérivés 2-OXO-1-Pyrrolidine, leurs procédés de préparation et leurs utilisations | |
| NO20054776L (no) | Kontrollert frigivelsessystem som inneholder sakkaroseacctatisobutyrat | |
| AR063096A1 (es) | Pirazolopirimidinas como inhibidores de quinasa dependientes de ciclina | |
| NO20090346L (no) | Pyrazolderivater som inhibitorer av cytokrom P450 | |
| NO20083250L (no) | Antibakterielle pyrrolopyridiner, pyrrolopyrimidiner og pyrroloazepiner | |
| NO20073572L (no) | Nye forbindelser | |
| NO20091999L (no) | MAPK/ERK kinase inhibitorer | |
| WO2007090661A3 (fr) | Combinaison de substances actives | |
| PL1864666T3 (pl) | Czynnik ochronny dla komórki neuronalnej siatkówki zawierający jako składnik aktywny pochodną prostaglandyny F2 alfa | |
| NO20055631L (no) | Doseringsform inneholdende pantoprazol som aktiv ingrediens | |
| DK1838665T3 (da) | Mutilinderivater og deres anvendelse som lægemidler | |
| WO2006002077A3 (fr) | Formulations pharmaceutiques stables de composes de benzimidazole | |
| WO2006120563A3 (fr) | Agents antibacteriens | |
| DK1729732T3 (da) | Anioniske hydrogelmatricer med pH-afhængig frigivelse som lægemiddelbærere | |
| WO2007143456A3 (fr) | Composés de benzimidazole thiophène | |
| WO2004078115A3 (fr) | Composes de benzothiazole, compositions et procedes pour le traitement et la prophylaxie des infections par rotavirus et des maladies associees |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |